REVBW

Revelation Biosciences, Inc. (NASDAQ:REVB) is a clinical-stage biopharmaceutical company founded in 2020 and headquartered in San Diego, California. The company went public in November 2020 and focuses on developing immune system therapeutics and diagnostics. As a relatively young biotech firm, Revelation operates without current revenue generation, dedicating its resources entirely to research and development of novel therapeutic candidates across multiple disease areas including respiratory conditions, chronic organ diseases, and infectious disease diagnostics.